Tarveda Therapeutics is a clinical stage biopharmaceutical company. We are taking a novel approach to the treatment of solid tumors through the use of our proprietary Pentarin® Platform. Pentarins are potent and target selective, miniature drug conjugates uniquely designed to drive efficacy deep into solid tumors. Through their miniature size, balanced with their high affinity for specific targets, tuned pharmacokinetics, tumor accumulation and sustained payload release, Pentarins are designed to trigger cancer cell death. We are developing therapeutics to address the limitations of current cancer therapies due to their large size, limited pharmacokinetics and other attributes that are suboptimal for the treatment of specific cancers.